OrthoPediatrics generated a total of $52.4 million in revenue in the first quarter of 2025, up 17% from $44.7 million in first quarter revenue in 2024.
Here are six additional things to know about the company’s Q1 revenue, according to a May 7 press release:
1. OrthoPediatrics treated nearly 39,000 patients in Q1.
2. Domestic revenue increased 19%, for the company, while international revenue increased 11%.
3. Trauma and deformity revenue grew 14% and worldwide scoliosis revenue grew 34% in the first quarter of 2025 compared to the first quarter of 2024.
4. OrthoPediatrics adjusted its full year 2025 revenue guidance to $236 million to $242 million from $235.0 million to $242.0 million, representing growth of 15% to 18% compared to prior year.
5. Total other income was $500,000 for the first quarter of 2025, compared to other expenses of $600,000 for the same period last year.
6. Net loss for the first quarter of 2025 was $10.7 million, compared to $7.8 million for the same period last year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
